Skip to main navigation Skip to search Skip to main content

EMPULSE: A multicentre, randomised, double-blind, 90-day superiority trial

Project: Research

Project Details

StatusFinished
Effective start/end date01/9/2004/30/24

Funding

  • Boehringer Ingelheim Pharmaceutical: $155,694.65